First human test: new Drug's safety checked in healthy volunteers
NCT ID NCT07211607
Summary
This is the first study testing a new drug called selonabant in people. Researchers want to see if it's safe and how the body handles it when given through an IV. They're enrolling 40 healthy adults aged 18-30 who will receive either the drug or a placebo. The main goal is to check for side effects and measure how the drug moves through and leaves the body.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes NO responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for HEALTHY VOLUNTEERS are added.
By submitting, you agree to our Terms of use
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
By submitting, you agree to our Terms of use
Study contacts
-
Contact
Phone: •••-•••-•••• Email: •••••@•••••
-
Contact
Phone: •••-•••-•••• Email: •••••@•••••
Locations
-
PPD Austin Clinical Research Unit
RECRUITINGAustin, Texas, 78744, United States
Contact Phone: •••-•••-•••• Email: •••••@•••••
Contact
Conditions
Explore the condition pages connected to this study.